Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  2,368 نتائج ل ""Glucagon-Like Peptides""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Association of bodyweight loss with changes in lipids, blood pressure, and fasting serum glucose following tirzepatide treatment in Japanese participants with type 2 diabetes: A post hoc analysis of the SURPASS J-mono trial.

  • Authors : Mimura H; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan.; Oura T

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/analysis ; Biomarkers*/Biomarkers*/Biomarkers*/blood ; Blood Glucose*/Blood Glucose*/Blood Glucose*/analysis

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2025 May; Vol. 16 (5), pp. 807-816. Date of Electronic Publication: 2025 Feb 01.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

Effectiveness for adding or switching from other incretin-related drugs to oral semaglutide in type 2 diabetes.

  • Authors : Oya J; Division of Diabetology and Metabolism, Department of Internal Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.; Shimizu M

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2025 Apr; Vol. 16 (4), pp. 608-614. Date of Electronic Publication: 2024 Dec 20.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

Semaglutide enhances PINK1/Parkin‑dependent mitophagy in hypoxia/reoxygenation‑induced cardiomyocyte injury.

  • Authors : Li L; Department of Endocrinology, The First Central Hospital of Baoding, Baoding, Hebei 071000, P.R. China.; Jin L

Subjects: Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/metabolism ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/drug effects ; Myocytes, Cardiac*/Myocytes, Cardiac*/Myocytes, Cardiac*/pathology

  • Source: Molecular medicine reports [Mol Med Rep] 2025 May; Vol. 31 (5). Date of Electronic Publication: 2025 Feb 28.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

Hedonic eating is controlled by dopamine neurons that oppose GLP-1R satiety.

  • Authors : Zhu Z; Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA.; Gong R

Subjects: Dopaminergic Neurons*/Dopaminergic Neurons*/Dopaminergic Neurons*/drug effects ; Dopaminergic Neurons*/Dopaminergic Neurons*/Dopaminergic Neurons*/physiology ; Dopaminergic Neurons*/Dopaminergic Neurons*/Dopaminergic Neurons*/metabolism

  • Source: Science (New York, N.Y.) [Science] 2025 Mar 28; Vol. 387 (6741), pp. eadt0773. Date of Electronic Publication: 2025 Mar 28.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

Effects of semaglutide in patients with chronic ankle instability: evidence from a prospective cohort.

  • Authors : Zhang J; National Center for Orthopaedics, Shanghai Sixth People's Hospital, No. 600 Yishan Road, Xuhui District, Shanghai, 200233, China.; Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai, 200233, China.

Subjects: Joint Instability*/Joint Instability*/Joint Instability*/drug therapy ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Ankle Joint*/Ankle Joint*/Ankle Joint*/drug effects

  • Source: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2025 Mar 06; Vol. 20 (1), pp. 243. Date of Electronic Publication: 2025 Mar 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-799X

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors Improve Renal Resistive Index in Patients With Type 2 Diabetes: A 26-Week Prospective Observational Real-Life Study.

  • Authors : Vozza A; Interdisciplinary Department of Medicine, School of Medicine, University of Bari 'Aldo Moro', Bari, Italy.; Volpe S

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

  • Source: Journal of diabetes research [J Diabetes Res] 2025 Feb 10; Vol. 2025, pp. 8182211. Date of Electronic Publication: 2025 Feb 10 (Print Publication: 2025).Publisher: Wiley Country of Publication: United States NLM ID: 101605237 Publication Model: eCollection Cited Medium: Internet ISSN: 2314-6753

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 Diabetes.

  • Authors : Choe HJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.; Nauck MA

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood

  • Source: Endocrinology and metabolism (Seoul, Korea) [Endocrinol Metab (Seoul)] 2025 Feb; Vol. 40 (1), pp. 156-160. Date of Electronic Publication: 2024 Nov 25.Publisher: Korean Endocrine Society Country of Publication: Korea (South) NLM ID: 101554139 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

Once-Weekly Semaglutide Versus Once-Daily Liraglutide for Weight Loss in Adults: A Meta-Analysis of Randomized Controlled Trials.

  • Authors : Hashmi TM; Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan.; Ahmed M

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/administration & dosage ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/adverse effects ; Liraglutide*/Liraglutide*/Liraglutide*/administration & dosage

  • Source: Clinical and translational science [Clin Transl Sci] 2025 Feb; Vol. 18 (2), pp. e70127.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

The Role of GLP-1 Agonists in Esthetic Medicine: Exploring the Impact of Semaglutide on Body Contouring and Skin Health.

  • Authors : Haykal D; Private Practice, Centre Laser Palaiseau, Palaiseau, France.; Hersant B

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/pharmacology ; Body Contouring*/Body Contouring*/Body Contouring*/methods

  • Source: Journal of cosmetic dermatology [J Cosmet Dermatol] 2025 Feb; Vol. 24 (2), pp. e16716. Date of Electronic Publication: 2024 Dec 08.Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر
×
Academic Journal

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease.

  • Authors : Cummings JL; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, NV, USA. .; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada, Las Vegas, NV, USA. .

Subjects: Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/therapeutic use ; Glucagon-Like Peptides*/Glucagon-Like Peptides*/Glucagon-Like Peptides*/adverse effects ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Jan 08; Vol. 17 (1), pp. 14. Date of Electronic Publication: 2025 Jan 08.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ أكثر
×
  • 1-10 ل  2,368 نتائج ل ""Glucagon-Like Peptides""